141 related articles for article (PubMed ID: 11328380)
1. Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.
Langhans B; Braunschweiger I; Schweitzer S; Jung G; Inchauspé G; Sauerbruch T; Spengler U
Immunology; 2001 Apr; 102(4):460-5. PubMed ID: 11328380
[TBL] [Abstract][Full Text] [Related]
2. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
3. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
[TBL] [Abstract][Full Text] [Related]
4. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
Zhu F; Eckels DD
Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
[TBL] [Abstract][Full Text] [Related]
5. Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides.
Langhans B; Braunschweiger I; Schweitzer S; Sauerbruch T; Spengler U
Vaccine; 2004 Mar; 22(11-12):1441-7. PubMed ID: 15063567
[TBL] [Abstract][Full Text] [Related]
6. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitro.
Langhans B; Schweitzer S; Nischalke HD; Braunschweiger I; Sauerbruch T; Spengler U
J Infect Dis; 2004 Jan; 189(2):248-53. PubMed ID: 14722889
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
9. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
[TBL] [Abstract][Full Text] [Related]
10. The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.
Löhr HF; Gerken G; Roth M; Weyer S; Schlaak JF; Meyer zum Büschenfelde KH
J Hepatol; 1998 Oct; 29(4):524-32. PubMed ID: 9824260
[TBL] [Abstract][Full Text] [Related]
11. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
Li S; Jones KL; Woollard DJ; Dromey J; Paukovics G; Plebanski M; Gowans EJ
Immunol Cell Biol; 2007; 85(3):197-204. PubMed ID: 17199111
[TBL] [Abstract][Full Text] [Related]
12. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.
Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
Hum Immunol; 2003 Feb; 64(2):224-30. PubMed ID: 12559624
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.
Lasarte JJ; García-Granero M; López A; Casares N; García N; Civeira MP; Borrás-Cuesta F; Prieto J
Hepatology; 1998 Sep; 28(3):815-22. PubMed ID: 9731578
[TBL] [Abstract][Full Text] [Related]
15. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection.
Iwata K; Wakita T; Okumura A; Yoshioka K; Takayanagi M; Wands JR; Kakumu S
Hepatology; 1995 Oct; 22(4 Pt 1):1057-64. PubMed ID: 7557851
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.
Woitas RP; Rockstroh JK; Beier I; Jung G; Kochan B; Matz B; Brackmann HH; Sauerbruch T; Spengler U
AIDS; 1999 Jul; 13(11):1313-22. PubMed ID: 10449283
[TBL] [Abstract][Full Text] [Related]
17. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.
Rowan AG; Fletcher JM; Ryan EJ; Moran B; Hegarty JE; O'Farrelly C; Mills KH
J Immunol; 2008 Oct; 181(7):4485-94. PubMed ID: 18802051
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.
Wang JH; Layden TJ; Eckels DD
Hum Immunol; 2003 Jul; 64(7):662-73. PubMed ID: 12826368
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice.
Kakimi K; Kuribayashi K; Iwashiro M; Masuda T; Sakai M; Ling W; Kubo Y; Kobayashi H; Higo K; Seki M
J Gen Virol; 1995 May; 76 ( Pt 5)():1205-14. PubMed ID: 7537326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
